Risk factors for Enterobacteriaceae bacteremia after liver transplantation

被引:46
作者
Bellier, Claire [1 ,2 ]
Bert, Frederic [3 ]
Durand, Francois [2 ,4 ]
Retout, Sylvie [5 ]
Belghiti, Jacques [2 ,6 ]
Mentre, France [5 ]
Fantin, Bruno [1 ,2 ]
机构
[1] Hop Beaujon, Dept Internal Med, AP HP, F-92110 Clichy, France
[2] Univ Paris 07, Sch Med, Paris, France
[3] Hop Beaujon, AP HP, Dept Microbiol, F-92110 Clichy, France
[4] Hop Beaujon, AP HP, Dept Hepatol, F-92110 Clichy, France
[5] Hop Bichat Claude Bernard, AP HP, Dept Biostat, F-75877 Paris, France
[6] Hop Beaujon, Dept Digest Surg, AP HP, F-92110 Clichy, France
关键词
bacteremia; Enterobacteriaceae; liver transplantation;
D O I
10.1111/j.1432-2277.2008.00673.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Enterobacteriaceae are now the predominant pathogens isolated in bloodstream infections complicating orthotopic liver transplantation (OLT). We conducted a retrospective cohort study of patients who underwent OLT in a University hospital between 01/01/1997 and 31/03/2003 to investigate the risk factors of Enterobacteriaceae bacteremia (EB) after OLT. EB was defined as the isolation of an Enterobacteriaceae species from at least one blood culture within 3 months following OLT. Pre-, per- and postoperative variables were collected from the medical records and analyzed in relation to EB. Forty (12.5%) of the 320 patients developed EB. The origin of EB was abdominal in 32% of the patients, urinary in 18%, pulmonary in 10%, and primary in the remaining 40% of the patients. Two-thirds of EB occurred within 1 month following OLT. The main pathogens were Escherichia coli (42%), Enterobacter cloacae (17%) and Klebsiella pneumoniae (17%). Susceptibility rates varied from 82.5% for ciprofloxacin to 95% for amikacin. Fourteen patients (35%) with EB died. Variables significantly associated with EB after multivariate analysis were a MELD score > 20 (OR: 2.79 [1.24-6.30], P = 0.013), transplantation for posthepatitic B (OR: 4.47 [1.67-11.98], P = 0.03) or posthepatitic C (OR: 3.79 [1.59-9.01], P = 0.03) cirrhosis, a positive bile culture (OR: 3.47 [1.19-10.13], P = 0.023) and return to surgery (including retransplantation) (OR: 2.72 [1.32-5.58], P = 0.006). EB is a frequent and severe complication following OLT. Patients grafted for a posthepatitic cirrhosis, with a severe pretransplantation status, with a positive bile culture and those undergoing reoperation have a high risk of developing EB.
引用
收藏
页码:755 / 763
页数:9
相关论文
共 30 条
[1]   Value of the MELD score for the assessment of pre- and post-liver transplantation survival [J].
Adler, M ;
De Gendt, E ;
Vereerstraeten, P ;
Degré, D ;
Bourgeois, N ;
Boon, N ;
Gelin, M ;
Ickx, B ;
Donckier, V .
TRANSPLANTATION PROCEEDINGS, 2005, 37 (06) :2863-2864
[2]  
Ben-Ari Z, 1998, TRANSPLANT INT, V11, P123
[3]   Risk factors for Staphylococcus aureus infection in liver transplant recipients [J].
Bert, R ;
Bellier, C ;
Lassel, L ;
Lefranc, V ;
Durand, F ;
Belghiti, J ;
Mentré, F ;
Fantin, B .
LIVER TRANSPLANTATION, 2005, 11 (09) :1093-1099
[4]   GRAM-NEGATIVE SEPSIS - A DILEMMA OF MODERN MEDICINE [J].
BONE, RC .
CLINICAL MICROBIOLOGY REVIEWS, 1993, 6 (01) :57-68
[5]   A systematic review of the performance of the Model for End-Stage Liver Disease (MELD) in the setting of liver transplantation [J].
Cholongitas, Evangelos ;
Marelli, Laura ;
Shusang, Vibhakorn ;
Senzolo, Marco ;
Rolles, Keith ;
Patch, David ;
Burroughs, Andrew K. .
LIVER TRANSPLANTATION, 2006, 12 (07) :1049-1061
[6]  
COLONNA JO, 1988, ARCH SURG-CHICAGO, V123, P360
[7]   Predicting outcome after liver transplantation: Utility of the model for end-stage liver disease and a newly derived discrimination function [J].
Desai, NM ;
Mange, KC ;
Crawford, MD ;
Abt, PL ;
Frank, AM ;
Markmann, JW ;
Velidedeoglu, E ;
Chapman, WC ;
Markmann, JF .
TRANSPLANTATION, 2004, 77 (01) :99-106
[8]  
Diekema DJ, 1999, CLIN INFECT DIS, V29, P595, DOI 10.1086/598640
[9]   Exposure to cytomegalovirus from the donated organ is a risk factor for bacteremia in orthotopic liver transplant recipients [J].
Falagas, ME ;
Snydman, DR ;
Griffith, J ;
Werner, BG ;
Rohrer, R ;
Freeman, R ;
Fawaz, K ;
Hoffman, MA ;
Kaplan, M ;
Gill, M ;
Rubin, RH ;
Dienstag, JL ;
Doran, M ;
ORourke, E ;
Vacanti, J ;
Jenkins, R ;
Lewis, WD ;
Hammer, S ;
Martin, M ;
Fairchild, R ;
Grady, GF ;
Leszczynski, J ;
Dougherty, N ;
Katz, A ;
Fausett, G ;
Platt, R ;
Cheeseman, SH ;
Pasternack, M ;
Gorbach, SL .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (03) :468-474
[10]   Gram-negative bacteremia in non-neutropenic patients: A 3-year review [J].
Gikas, A ;
Samonis, G ;
Christidou, A ;
Papadakis, J ;
Kofteridis, D ;
Tselentis, Y ;
Tsaparas, N .
INFECTION, 1998, 26 (03) :155-159